Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies

乳腺癌 医学 肿瘤科 癌症 内科学 靶向治疗 肿瘤微环境 曲妥珠单抗 免疫疗法 癌症研究
作者
Yu-Wei Li,Lei-Jie Dai,Xiangrong Wu,Shen Zhao,Yu-Zheng Xu,Xi Jin,Yi Xiao,Ying Wang,Cai-Jin Lin,Yi-Fan Zhou,Tong Fu,Wentao Yang,Ming Li,Hong Lv,Siyuan Chen,Anita Grigoriadis,Yi‐Zhou Jiang,Ding Ma,Zhi‐Ming Shao
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (21): 3669-3683 被引量:13
标识
DOI:10.1158/0008-5472.can-23-4066
摘要

HER2-positive breast cancer is an aggressive subtype that accounts for 15% to 20% of all breast cancers. Recent studies have suggested that HER2-positive breast cancer is a group of heterogeneous diseases with different sensitivities to standard treatment regimens. Revealing the molecular heterogeneity of HER2-positive breast cancer could potentially enable more precise treatment strategies. In this study, we performed multiomics profiling on a HER2-positive breast cancer cohort and identified four transcriptome-based subtypes. The classical HER2 (HER2-CLA) subtype comprised 28.3% of the samples and displayed high ERBB2 activation and significant benefit from anti-HER2 therapy. The immunomodulatory (HER2-IM) subtype (20%) featured an immune-activated microenvironment, potentially suitable for de-escalated treatment and immunotherapy. The luminal-like (HER2-LUM) subtype (30.6%) possessed similar molecular features of hormone receptor-positive HER2-negative breast cancer, suggesting endocrine therapy and CDK4/6 inhibitors as a potential therapeutic strategy. Lastly, the basal/mesenchymal-like (HER2-BM) subtype (21.1%) had a poor response to current dual HER2-targeted therapy and could potentially benefit from tyrosine kinase inhibitors. The molecular characteristics and clinical features of the subtypes were further explored across multiple cohorts, and the feasibility of the proposed treatment strategies was validated in patient-derived organoid and patient-derived tumor fragment models. This study elucidates the molecular heterogeneity of HER2-positive breast cancer and paves the way for a more tailored treatment. Significance: Illumination of the inherent heterogeneity within HER2-positive breast cancers through the delineation of distinct molecular subtypes lays the groundwork for developing more personalized treatment strategies based on specific patient characteristics.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ysssbq完成签到,获得积分10
1秒前
2秒前
上好佳完成签到 ,获得积分10
2秒前
大模型应助Yeong采纳,获得10
3秒前
量子星尘发布了新的文献求助30
3秒前
4秒前
123完成签到,获得积分10
4秒前
谢陈完成签到 ,获得积分10
5秒前
lilili完成签到,获得积分10
6秒前
7秒前
xiaoying发布了新的文献求助10
7秒前
SciGPT应助Eric_Liuzy采纳,获得10
8秒前
liu完成签到 ,获得积分10
8秒前
qixiaoqi发布了新的文献求助10
9秒前
10秒前
A溶大美噶发布了新的文献求助10
10秒前
11秒前
11秒前
12秒前
13秒前
14秒前
kevin发布了新的文献求助10
14秒前
满意的初南完成签到 ,获得积分10
15秒前
橙橙橙发布了新的文献求助10
15秒前
万能图书馆应助EVEN采纳,获得10
15秒前
15秒前
Yeong发布了新的文献求助10
16秒前
范先生发布了新的文献求助10
17秒前
disciple完成签到,获得积分10
18秒前
沉默凌寒完成签到,获得积分10
18秒前
cc完成签到,获得积分10
18秒前
19秒前
糖豆完成签到,获得积分10
19秒前
smottom完成签到,获得积分0
20秒前
贰鸟完成签到,获得积分0
20秒前
20秒前
火山蜗牛发布了新的文献求助10
21秒前
腿毛没啦完成签到,获得积分10
21秒前
21秒前
Japan完成签到,获得积分10
21秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
Research on Disturbance Rejection Control Algorithm for Aerial Operation Robots 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038569
求助须知:如何正确求助?哪些是违规求助? 3576279
关于积分的说明 11374944
捐赠科研通 3305979
什么是DOI,文献DOI怎么找? 1819354
邀请新用户注册赠送积分活动 892698
科研通“疑难数据库(出版商)”最低求助积分说明 815048